Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Wellcome Open Research|September 25, 2023
-Pharmacokinetics of antimalarial drugs used to treat uncomplicated malaria in breastfeeding mother-infant pairs: An observational pharmacokinetic studyRitah Nakijoba, Aida Nakayiwa Kawuma, Francis Williams Ojara, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2023
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicinAllan Kengo, Kamunkhwala Gausi, Ruth Nabisere, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2023
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicinAllan Kengo, Ruth Nabisere, Kamunkhwala Gausi, et al.
BMJ Open|September 21, 2017
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH studyChristine Sekaggya-Wiltshire, Barbara Castelnuovo, Amrei von Braun, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 2, 2024
Interim analysis, a tool to enhance efficiency of pharmacokinetic studies: Pharmacokinetics of rifampicin in lactating mother-infant pairsAida N Kawuma, Francis Williams Ojara, Allan Buzibye, et al.
AIDS Research and Therapy|April 2, 2023
Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional studyAllan Buzibye, Kara Wools-Kaloustian, Adeniyi Olagunju, et al.
HIV Medicine|January 24, 2025
A programmatic assessment of dolutegravir adverse events and discontinuations in UgandaEva Agnes Laker Odongpiny, Melanie Nicol, Elizabeth Katana, et al.
AIDS Research and Therapy|December 8, 2019
Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control studyAllan Buzibye, Joseph Musaazi, Amrei von Braun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2015
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 WeeksKimberly K Scarsi, Kristin M Darin, Shadia Nakalema, et al.
AIDS Research and Therapy|September 27, 2025
Dolutegravir-associated hyperglycemia: a narrative reviewAllan Buzibye, Barbara Castelnuovo, Robert C Bollinger, et al.
Pageof 3